MENU
GDOC
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

GDOC stock forecast, quote, news & analysis

The investment seeks long-term growth of capital... Show more

Category: #Health
GDOC
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for GDOC with price predictions
Oct 01, 2026

GDOC in upward trend: price rose above 50-day moving average on September 18, 2026

GDOC moved above its 50-day moving average on September 18, 2026 date and that indicates a change from a downward trend to an upward trend. In 36 of 40 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 52 cases where GDOC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Momentum Indicator moved above the 0 level on September 23, 2026. You may want to consider a long position or call options on GDOC as a result. In 63 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for GDOC just turned positive on October 01, 2026. Looking at past instances where GDOC's MACD turned positive, the stock continued to rise in 36 of 49 cases over the following month. The odds of a continued upward trend are 73%.

The 10-day moving average for GDOC crossed bullishly above the 50-day moving average on September 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.

GDOC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day RSI Indicator for GDOC moved out of overbought territory on August 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 23 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.

The Aroon Indicator for GDOC entered a downward trend on September 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), Guardant Health (NASDAQ:GH).

Industry description

The investment seeks long-term growth of capital. The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments in U.S. and non‑U.S. health care companies. The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare. The fund is non-diversified.

Market Cap

The average market capitalization across the Future Health Care Equity ETF (GDOC) ETF is 94.42B. The market cap for tickers in the group ranges from 1.38B to 1.06T. LLY holds the highest valuation in this group at 1.06T. The lowest valued company is KARD at 1.38B.

High and low price notable news

The average weekly price growth across all stocks in the Future Health Care Equity ETF (GDOC) ETF was 8%. For the same ETF, the average monthly price growth was 49%, and the average quarterly price growth was 313%. TXG experienced the highest price growth at 6%, while GPCR experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the Future Health Care Equity ETF (GDOC) ETF was -4%. For the same stocks of the ETF, the average monthly volume growth was 24% and the average quarterly volume growth was 1%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 54
Price Growth Rating: 50
SMR Rating: 65
Profit Risk Rating: 71
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
GDOC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
Goldman Sachs ETF Trust200 West StreetNew York
Phone
(212) 902-1000
Web
am.gs.com
GDOC in upward trend: price rose above 50-day moving average on September 18, 2026